ASN 2026 21 - 25 October 2026

Prognostic Significance of eGFR Change at Week 12 on Kidney Outcomes Associated with Semaglutide Use in the FLOW Trial

Authors :

Allon Friedman¹; Katherine R. Tuttle^2,3; Kenneth W. Mahaffey⁴; Richard E. Pratley⁵; Peter Rossing^6,7; Willem A. Bax⁸; Srikanth Bellary⁹; David M. Charytan¹⁰; Jose Luis Górriz^11,12; Linong Ji¹³; Giuseppe Pugliese¹⁴; Brian Rayner¹⁵; Roland E. Schmieder¹⁶; Trine W. Boesgaard¹⁷; Prachi Priyadarshini¹⁸; Søren Rasmussen¹⁷; David Z. I. Cherney^19,20

Affiliations

View Details Hide Details

Keywords

Chronic Kidney Disease

Congress short oral presentation

GLP-1 RA

Semaglutide

Search Science Hub

Are you a healthcare professional?

Prognostic Significance of eGFR Change at Week 12 on Kidney Outcomes Associated with Semaglutide Use in the FLOW Trial